Spontaneous Retroperitoneal Bleeding as a Complication of Unusual Renal Paraganglioma
Corresponding Author
Tawfeeq I. Sangey
TMJ Super Specialized Polyclinic, Dar Es Salaam, Tanzania
Search for more papers by this authorHamim Abdul Rusheke
School of Medicine and Dentistry, University of Dodoma, Dodoma, Tanzania udom.ac.tz
Search for more papers by this authorAnsaar I. Sangey
Muhimbili National Hospital, Dar Es Salaam, Tanzania mnh.or.tz
Search for more papers by this authorAdvera Ngaiza
Muhimbili National Hospital, Dar Es Salaam, Tanzania mnh.or.tz
Search for more papers by this authorCorresponding Author
Tawfeeq I. Sangey
TMJ Super Specialized Polyclinic, Dar Es Salaam, Tanzania
Search for more papers by this authorHamim Abdul Rusheke
School of Medicine and Dentistry, University of Dodoma, Dodoma, Tanzania udom.ac.tz
Search for more papers by this authorAnsaar I. Sangey
Muhimbili National Hospital, Dar Es Salaam, Tanzania mnh.or.tz
Search for more papers by this authorAdvera Ngaiza
Muhimbili National Hospital, Dar Es Salaam, Tanzania mnh.or.tz
Search for more papers by this authorAbstract
Spontaneous retroperitoneal bleeding is a rare occurrence that might have catastrophic implications. We present a 58-year-old male with a 4-day history of progressively worsening left-sided flank pain due to retroperitoneal hemorrhage from a nonfunctional renal paraganglioma. Abdominal contrast CT scan was helpful in locating the tumor, estimating tumor size and extent of bleeding, visualizing the interaction between the tumor and the surroundings, and ruling out any potential metastasis; however, it lacked specificity in identifying the origin of the mass, needing histologic investigation for a conclusive diagnosis. MRI was not available at our center. We report a rare case of spontaneous retroperitoneal bleeding as a complication of an unusual nonfunctional renal paraganglioma, which was initially misdiagnosed as renal cell carcinoma but later confirmed by postoperative histopathology.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
References
- 1 Tevosian S. G. and Ghayee H. K., Pheochromocytomas and Paragangliomas, Endocrinology and Metabolism Clinics of North America. W.B. Saunders. (2019) 48, 727–750.
- 2 Berends A. M. A., Buitenwerf E., de Krijger R. R., Veeger N. J. G. M., van der Horst-Schrivers A. N. A., Links T. P., and Kerstens M. N., Incidence of pheochromocytoma and sympathetic paraganglioma in The Netherlands: a nationwide study and systematic review, European Journal of Internal Medicine. (2018) 51, 68–73, https://doi.org/10.1016/j.ejim.2018.01.015, 2-s2.0-85040588559.
- 3 Leung A. A., Pasieka J. L., Hyrcza M. D., Pacaud D., Dong Y., Boyd J. M., Sadrzadeh H., and Kline G. A., Epidemiology of pheochromocytoma and paraganglioma: population-based cohort study, European Journal of Endocrinology. (2021) 184, no. 1, 19–28, https://doi.org/10.1530/eje-20-0628.
- 4 Lam A. K., Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours, Endocrine Pathology. (2017) 28, 213–227.
- 5 Neumann H. P. H., Young W. F., and Eng C., Pheochromocytoma and paraganglioma, New England Journal of Medicine. (2019) 381, no. 6, 552–565, https://doi.org/10.1056/nejmra1806651, 2-s2.0-85070618547.
- 6 Erickson D., Kudva Y. C., Ebersold M. J., Thompson G. B., Grant C. S., and van Heerden J. A., Benign Paragangliomas: clinical presentation and treatment outcomes in 236 patients, The Journal of Clinical Endocrinology & Metabolism. (2001) 86.
- 7 Zhao L., Luo J., Zhang H., and Da J., Pigmented paraganglioma of the kidney: a case report, Diagnostic Pathology. (2012) 7, no. 1, https://doi.org/10.1186/1746-1596-7-77, 2-s2.0-84862774800.
- 8 Song M., Sun K., Xia T., Zhou L., Li Y., Sun Z., Zhang Y., Zhang X., Sun R., Chen B., and Tan Q., Malignant pheochromocytoma in the anterior mediastinum with sternal invasion: a case report, Journal of Thoracic Disease. (2017) 9, no. 3, E202–E209, https://doi.org/10.21037/jtd.2017.02.71, 2-s2.0-85016469402.
- 9 Saha A., Saha K., Sarkar N., and Geelani I. A., Paraganglioma of urinary bladder: an uncommon entity in uropathology, Cureus. 2021Aug 18, 13, no. 8, e17265, https://doi.org/10.7759/cureus.17265.
- 10 Aygun N., Pheochromocytoma and Paraganglioma: From Epidemiology to Clinical Findings, 2020, SiSli Etfal Hastanesi Tip Bulteni/The Medical Bulletin of Sisli Hospital, Istanbul, Turkey.
- 11 Al-Harthy M., Al-Harthy S., Al-Otieschan A., Velagapudi S., and Alzahrani A. S., Original Article comparison of pheochromocytomas AND abdominal AND pelvic paragangliomas with head and neck paragangliomas, Endocrine Practice. (2009) 15, no. 194.
- 12 Falhammar H., Kjellman M., and Calissendorff J., Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center, Endocrine Connections. (2018) 7, no. 1, 186–192, https://doi.org/10.1530/ec-17-0321, 2-s2.0-85041283678.
- 13 Garrett R. W., Nepute J. C., Hayek M. E., and Albert S. G., Adrenal incidentalomas: clinical controversies and modified recommendations, American Journal of Roentgenology. (2016) 206, no. 6, 1170–1178, https://doi.org/10.2214/ajr.15.15475, 2-s2.0-84999098810.
- 14 Shah R. D., Nagar S., Shanley C. J., and Janczyk R. J., Factors affecting the severity of spontaneous retroperitoneal hemorrhage in anticoagulated patients, The American Journal of Surgery. (2008) 195, no. 3, 410–413, https://doi.org/10.1016/j.amjsurg.2007.12.003, 2-s2.0-40749103374.
- 15 Antonescu O., Duhamel M., di Giacinto B., and Spain J., Spontaneous renal hemorrhage: a case report and clinical protocol, Cureus. (2021) 13, no. 6, e15547, https://doi.org/10.7759/cureus.15547.
- 16 Durak D., Eren F., Nursel, İnanir T., Eren B., and Çetin S., Spontaneous rupture of a renal cell carcinoma associated with fatal bleeding, Journal of Clinical Medicine Case Reports Case Reports 275 Maedica A Journal of Clinical Medicine. (2014) 9.
- 17
Singh A., Extra-adrenal retroperitoneal paraganglioma: report of a rare case, International Journal of Molecular Biology. (2017) 2, no. 5, https://doi.org/10.15406/ijmboa.2017.02.00034.
10.15406/ijmboa.2017.02.00034 Google Scholar
- 18
FitzGerald S. C.,
Gingell L. M.,
Parnaby C. N.,
Connell J. M., and
O’Dwyer P. J., Abdominal paragangliomas: analysis of surgeon’s experience, World Journal of Endocrine Surgery. (2011) 3, no. 2, 55–58, https://doi.org/10.5005/jp-journals-10002-1057.
10.5005/jp-journals-10002-1057 Google Scholar
- 19
Hofko M.,
Hergan B., and
A Fellner F., Incidental retroperitoneal paraganglioma, imaging workup and CT-guided biopsy: a case report, Global Imaging Insights. (2020) 5, no. 2, https://doi.org/10.15761/gii.1000201.
10.15761/GII.1000201 Google Scholar
- 20 Kimura N., Takekoshi K., and Naruse M., Risk stratification on pheochromocytoma and paraganglioma from laboratory and clinical medicine, Journal of Clinical Medicine. (2018) 7.
- 21 Brahmbhatt P., Patel P., Saleem A., Narayan R., and Young M., Retroperitoneal paraganglioma presenting as a chest pain: a case report, Case Reports in Oncological Medicine. (2013) 2013, 4, 329472, https://doi.org/10.1155/2013/329472.
- 22 Yi C., Han L., Yang R., and Yu J., Paraganglioma of the renal pelvis: a case report and review of literature, Tumori. (2017) 103, no. 1_suppl, S47–S49, https://doi.org/10.5301/tj.5000677, 2-s2.0-85038129332.
- 23 Hempenstall L. E., Siriwardana A. R., and Desai D. J., Investigation of a renal mass: diagnosing renal paraganglioma, Urology Case Reports. (2018) 21, 8–9, https://doi.org/10.1016/j.eucr.2018.08.001, 2-s2.0-85051377572.
- 24 Asa S. L., Ezzat S., and Mete O., The diagnosis and clinical significance of paragangliomas in unusual locations, Journal of Clinical Medicine. (2018) 7.
- 25 Kopetschke R., Slisko M., Kilisli A., Tuschy U., Wallaschofski H., Fassnacht M., Ventz M., Beuschlein F., Reincke M., Reisch N., and Quinkler M., Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma, European Journal of Endocrinology. (2009) 161, no. 2, 355–361, https://doi.org/10.1530/eje-09-0384, 2-s2.0-68349145047.
- 26 Bahar B., Pambuccian S. E., Gupta G. N., and Barkan G. A., Renal paraganglioma: report of a case managed by robotic assisted laparoscopic partial nephrectomy and review of the literature, Case Reports in Urology. (2014) 2014, 6, 527592, https://doi.org/10.1155/2014/527592.
- 27 Y-Hassan S. and Falhammar H., Cardiovascular manifestations and complications of pheochromocytomas and paragangliomas, Journal of Clinical Medicine. (2020) 9, 1–19.
- 28 Meijs A. C., Snel M., and Corssmit E. P. M., TEACHING CASE PRESENTATIONS Pheochromocytoma/paraganglioma Crisis: Case Series from a Tertiary Referral Center for Pheochromocytomas and Paragangliomas, 2000, https://doi.org/10.1007/s42000-021-00274-6.
- 29 Schifferdecker B., Kodali D., Hausner E., and Aragam J., Adrenergic shock—an overlooked clinical entity?, Cardiology in Review. (2005) 13, no. 2, 69–72, https://doi.org/10.1097/01.crd.0000151679.16187.2f, 2-s2.0-14044270745.
- 30 Lenders J. W. M., Duh Q. Y., Eisenhofer G., Gimenez-Roqueplo A. P., Grebe S. K. G., and Murad M. H., Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline, Journal of Clinical Endocrinology and Metabolism. Endocrine Society. (2014) 99, 1915–1942.
- 31 Timmers H. J. L. M., Pacak K., Huynh T. T., Abu-Asab M., Tsokos M., Merino M. J., Baysal B. E., Adams K. T., and Eisenhofer G., Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene, The Journal of Clinical Endocrinology & Metabolism. (2008) 93, no. 12, 4826–4832, https://doi.org/10.1210/jc.2008-1093, 2-s2.0-57349179033.
- 32 Gannan E., van Veenendaal P., Scarlett A., and Ng M., Retroperitoneal non-functioning paraganglioma: a difficult tumour to diagnose and treat, International Journal of Surgery Case Reports. (2015) 17, 133–135, https://doi.org/10.1016/j.ijscr.2015.11.004, 2-s2.0-84966378364.
- 33 Clifton-Bligh R., Diagnosis of silent pheochromocytoma and paraganglioma, Expert Review of Endocrinology and Metabolism. (2013) 8, no. 1, 47–57, https://doi.org/10.1586/eem.12.76, 2-s2.0-84871551982.
- 34 Woo S., Suh C. H., Kim S. Y., Cho J. Y., and Kim S. H., Pheochromocytoma as a frequent false-positive in adrenal washout CT: a systematic review and meta-analysis, European Radiology. (2018) 28, no. 3, 1027–1036, https://doi.org/10.1007/s00330-017-5076-5, 2-s2.0-85031407285.
- 35 Hamrahian A. H., Ioachimescu A. G., Remer E. M., Motta-Ramirez G., Bogabathina H., Levin H. S., Reddy S., Gill I. S., Siperstein A., and Bravo E. L., Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: cleveland clinic experience, The Journal of Clinical Endocrinology & Metabolism. (2005) 90, no. 2, 871–877, https://doi.org/10.1210/jc.2004-1627, 2-s2.0-20044384532.
- 36
Motta-Ramirez G. A.,
Remer E. M.,
Herts B. R.,
Gill I. S., and
Hamrahian A. H., Comparison of CT Findings in Symptomatic and Incidentally Discovered Pheochromocytomas, 2005, https://www.ajronline.org.
10.2214/ajr.185.3.01850684 Google Scholar
- 37 Ctvrtlik F., Tudos Z., Szasz P., Sedlackova Z., Hartmann I., Schovanek J., Frysak Z., Macova I., Zelinka T., Hora M., Kocova E., Pacovsky J., Krsek M., Lehotska V., Mojtova E., Molnar J., Vanek V., Pacak K., and Baxa J., Characteristic CT features of pheochromocytomas—probability model calculation tool based on a multicentric study, Biomedical Papers. (2019) 163, no. 3, 212–219, https://doi.org/10.5507/bp.2019.047, 2-s2.0-85072716561.
- 38 Lee K. Y., Oh Y. W., Noh H. J., Lee Y. J., Yong H. S., Kang E. Y., Kim K. A., and Lee N. J., Extraadrenal paragangliomas of the body: imaging features, American Journal of Roentgenology. (2006) 187, no. 2, 492–504, https://doi.org/10.2214/ajr.05.0370, 2-s2.0-33746624711.
- 39 Yau K. K., Siu W. T., and Ka-Wah Li M., Unusual cause of acute abdomen-ruptured retroperitoneal paraganglioma, Asian Journal Of Surgery. (2008) 31.
- 40
Yang Y.,
Wang G.,
Lu H.,
Liu Y.,
Ning S., and
Luo F., Haemorrhagic retroperitoneal paraganglioma initially manifesting as acute abdomen: a rare case report and literature review, BMC Surgery. (2020) 304, no. 1, https://doi.org/10.1186/s12893-020-00953-y.
10.1186/s12893-020-00953-y Google Scholar
- 41 Kobayashi T., Iwai A., Takahashi R., Ide Y., Nishizawa K., and Mitsumori K., Spontaneous rupture of adrenal pheochromocytoma: review and analysis of prognostic factors, Journal of Surgical Oncology. (2005) 90, no. 1, 31–35, https://doi.org/10.1002/jso.20234, 2-s2.0-15944363032.
- 42 Hamidi O., Young W. F., Iñiguez-Ariza N. M., Kittah N. E., Gruber L., Bancos C., Tamhane S., and Bancos I., Malignant pheochromocytoma and paraganglioma: 272 patients over 55 years, The Journal of Clinical Endocrinology & Metabolism. (2017) 102, no. 9, 3296–3305, https://doi.org/10.1210/jc.2017-00992, 2-s2.0-85031049270.
- 43 Suga K., Motoyama K., Hara A., Kume N., Ariga M., and Matsunaga N., Tc-99m MIBG imaging in a huge clinically silent pheochromocytoma with cystic degeneration and massive hemorrhage, Clinical Nuclear Medicine. (2000) 25.
- 44 Goffredo P., Sosa J. A., and Roman S. A., Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades, Journal of Surgical Oncology. (2013) 107, no. 6, 659–664, https://doi.org/10.1002/jso.23297, 2-s2.0-84876415724.
- 45 Kim K. Y., Kim J. H., Hong A. R., Seong M. W., Lee K. E., Kim S. J., Kim S. W., Shin C. S., and Kim S. Y., Disentangling of malignancy from benign pheochromocytomas/paragangliomas, PLoS One. (2016) 11, no. 12, e0168413, https://doi.org/10.1371/journal.pone.0168413, 2-s2.0-85006494096.
- 46 Thompson L. D. R., Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign from Malignant Neoplasms A Clinicopathologic and Immunophenotypic Study of 100 Cases, 2002, 26, no. 5, 551–566.
- 47 Li H. Z., Ji G., Mao Q., Shi B., Wen J., and Yan W., A decade of clinical experience with extra-adrenal paragangliomas of retroperitoneum: report of 67 cases and a literature review, Urology Annals. (2010) 2, no. 1, https://doi.org/10.4103/0974-7796.62919.
- 48 Kinney M. A. O., Warner M. E., Vanheerden J. A., Horlocker T. T., Young W. F., and Schroeder D. R., Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection Anesthesia and Analgesia, 2000, 91.
- 49 Liu H., Li B., Yu X., and Huang Y., Preoperative risk factors for massive blood loss in adrenalectomy for pheochromocytoma, 2017, https://www.impactjournals.com/oncotarget.
- 50 Amar L., Lussey-Lepoutre C., Lenders J. W. M., Djadi-Prat J., Plouin P. F., and Steichen O., Recurrence or new tumors after complete resection of phaeochromocytomas and paragangliomas. a systematic review and meta-analysis, European Journal of Endocrinology. (2016) 175, no. 4.